Payment overview · 2025
General Payments
$38.54
1 reported records · 1 companies
Healthcare provider profile · identity verified
Joe A Bilyeu, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · PETERSBURG, IL · NPI 1023230968
Verified facts
What the public records show
CMS Open Payments records show Joe A Bilyeu, M.D. received $38.54 in general payments during 2025 across 1 reported records.
Lundbeck LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lundbeck LLC | Unresolved — no canonical attribution shown | $38.54 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $38.54 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $38.54 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 725 | 160 |
| Lisinopril | Lisinopril | 636 | 141 |
| Furosemide | Furosemide | 521 | 98 |
| Eliquis | Apixaban | 454 | 62 |
| Omeprazole | Omeprazole | 436 | 79 |
| Metoprolol Succinate | Metoprolol Succinate | 432 | 101 |
| Hydrochlorothiazide | Hydrochlorothiazide | 416 | 93 |
| Levothyroxine Sodium | Levothyroxine Sodium | 394 | 80 |
| Amlodipine Besylate | Amlodipine Besylate | 349 | 78 |
| Gabapentin | Gabapentin | 325 | 57 |
| Metformin Hcl | Metformin Hcl | 301 | 67 |
| Losartan Potassium | Losartan Potassium | 289 | 60 |
| Tamsulosin Hcl | Tamsulosin Hcl | 285 | 55 |
| Metoprolol Tartrate | Metoprolol Tartrate | 270 | 48 |
| Potassium Chloride | Potassium Chloride | 267 | 48 |
| Warfarin Sodium | Warfarin Sodium | 264 | 31 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 263 | 61 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 245 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 237 | 49 |
| Pravastatin Sodium | Pravastatin Sodium | 218 | 33 |
| Atenolol | Atenolol | 210 | 44 |
| Citalopram Hbr | Citalopram Hydrobromide | 201 | 38 |
| Glipizide | Glipizide | 185 | 41 |
| Allopurinol | Allopurinol | 183 | 37 |
| Sertraline Hcl | Sertraline Hcl | 176 | 36 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 170 | 40 |
| Lovastatin | Lovastatin | 159 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 155 | 36 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 155 | 22 |
| Meloxicam | Meloxicam | 151 | 30 |
| Fluoxetine Hcl | Fluoxetine Hcl | 146 | 33 |
| Montelukast Sodium | Montelukast Sodium | 146 | 25 |
| Carvedilol | Carvedilol | 135 | 26 |
| Glipizide Er | Glipizide | 131 | 26 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 128 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 117 | 20 |
| Nifedipine Er | Nifedipine | 117 | 20 |
| Famotidine | Famotidine | 113 | 29 |
| Januvia | Sitagliptin Phosphate | 107 | 15 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 106 | 77 |
| Ropinirole Hcl | Ropinirole Hcl | 103 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 100 | 26 |
| Lorazepam | Lorazepam | 99 | 36 |
| Alprazolam | Alprazolam | 98 | 20 |
| Ezetimibe | Ezetimibe | 98 | 19 |
| Simvastatin | Simvastatin | 97 | 23 |
| Trazodone Hcl | Trazodone Hcl | 96 | 18 |
| Spironolactone | Spironolactone | 94 | 16 |
| Xarelto | Rivaroxaban | 93 | 15 |
| Metformin Hcl Er | Metformin Hcl | 85 | 16 |
| Buspirone Hcl | Buspirone Hcl | 83 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 81 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 77 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 77 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 75 | 12 |
| Bumetanide | Bumetanide | 74 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 71 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 71 | 19 |
| Diclofenac Sodium | Diclofenac Sodium | 70 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 67 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 66 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 57 | suppressed |
| Lamotrigine | Lamotrigine | 56 | suppressed |
| Fenofibrate | Fenofibrate | 54 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 52 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 51 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 50 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 49 | suppressed |
| Finasteride | Finasteride | 48 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 47 | 47 |
| Escitalopram Oxalate | Escitalopram Oxalate | 47 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 47 | suppressed |
| Lactulose | Lactulose | 46 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 46 | suppressed |
| Clonazepam | Clonazepam | 44 | suppressed |
| Memantine Hcl | Memantine Hcl | 44 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 44 | 16 |
| Entresto | Sacubitril/Valsartan | 42 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 40 | 30 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 40 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 37 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 37 | suppressed |
| Lansoprazole | Lansoprazole | 37 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 36 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 36 | suppressed |
| Jardiance | Empagliflozin | 36 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 36 | suppressed |
| Azithromycin | Azithromycin | 35 | 29 |
| Bupropion Hcl | Bupropion Hcl | 35 | suppressed |
| Amoxicillin | Amoxicillin | 34 | 20 |
| Digoxin | Digoxin | 34 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 34 | suppressed |
| Ranolazine Er | Ranolazine | 33 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 30 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 29 | suppressed |
| Bupropion Xl | Bupropion Hcl | 29 | suppressed |
| Fluconazole | Fluconazole | 29 | 13 |
| Gemfibrozil | Gemfibrozil | 29 | suppressed |
| Prednisone | Prednisone | 29 | 22 |
| Topiramate | Topiramate | 29 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 29 | suppressed |
| Baclofen | Baclofen | 28 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 28 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 27 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 26 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 21 |
| Oxcarbazepine | Oxcarbazepine | 25 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Pregabalin | Pregabalin | 24 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 19 |
| Flecainide Acetate | Flecainide Acetate | 23 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Ramipril | Ramipril | 23 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 22 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 22 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 21 | 19 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 21 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Nystatin | Nystatin | 19 | 11 |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Ozempic | Semaglutide | 19 | suppressed |
| Fentanyl | Fentanyl | 18 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 18 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 18 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 18 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Glimepiride | Glimepiride | 16 | suppressed |
| Nabumetone | Nabumetone | 16 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 14 |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 15 | suppressed |
| Torsemide | Torsemide | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Latanoprost | Latanoprost | 14 | suppressed |
| Mirtazapine | Mirtazapine | 14 | suppressed |
| Trueplus Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Eplerenone | Eplerenone | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Felodipine Er | Felodipine | 13 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Savella | Milnacipran Hcl | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Haloperidol | Haloperidol | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 12 | suppressed |
| Trimethoprim | Trimethoprim | 12 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $38.54 · 1 records | Lundbeck LLC | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error